Menu Back toPandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance

DIA 2021 Global Annual Meeting


Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance

Session Chair(s)

Lisa  Wittmer, PhD

Lisa Wittmer, PhD

  • President
  • Theorogen Consulting, United States
Antimicrobial resistance (AMR) is a threat to global health. Reactive efforts to address AMR risks lives, economies, and security. A proactive preparedness model relies on innovation in development and regulatory pathways.
Learning Objective : Review the current regulatory framework in the context of increasing AMR; Discuss regulator’s role in ensuring development feasibility; Identify areas for improvement.

Speaker(s)

Sumathi  Nambiar, MD, MPH

Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance

Sumathi Nambiar, MD, MPH

  • Senior Director, Child Health and Innovation Leadership Department
  • Johnson & Johnson, United States
Marco  Cavaleri, PhD

EMA Update

Marco Cavaleri, PhD

  • Head of Biological Health Threats and Vaccines Strategy
  • European Medicines Agency, Netherlands
Paul Christopher McGovern

Panelist

Paul Christopher McGovern

  • Vice President, Medical Sciences
  • Venatorx Pharmaceuticals, Inc., United States